CLEC-2 is an essential molecule in both processes, capable of modulating platelet activation during hemostasis, thrombosis, and tumor metastasis, which is why it has been considered a good candidate for treatments against cancer metastasis and cancer-associated thrombosis. Here, CLEC1B is linked to cancer.